United States DC Circuit
Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 04-5350a.pdf
Where there are no alternative government-approved treatment options, a terminally ill, mentally competent adult patient's informed access to potentially life-saving investigational new drugs determined by the FDA after Phase I trials to be sufficiently safe for expanded human trials is protected under the Due Process Clause.
Appellate Information
- Decided 05/02/2006
- Published 05/02/2006
Judges
Court
- United States DC Circuit